Author

Aled Blundell

University of Toronto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Landon J. EdgariD· 2 shared Ali SalahpouriD· 1 shared Ameneh RezayofiD· 1 shared Amy J. RamseyiD· 1 shared Conner W. WallaceiD· 1 shared David B. Avila· 1 shared David G. BrooksiD· 1 shared Dawn E. Watkins‐ChowiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Landon J. EdgarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Unified Atlas of T cell Glycophysiology

Fauzia N. Izzati, Hani Choksi, Paolo Giuliana, Diala Abd-Rabbo, Heidi J. Elsaesser, Aled Blundell, Vanessa Affe, Vinicius Kannen, Zeinab Jame-Chenarboo, Edward N. Schmidt, Meggie Kuypers, David B. Avila, Eric S. Y. Chiu, Dzhangar Badmaev, Haissi Cui, , Landon J. Edgar

This study characterizes T cell glycosylation patterns across mouse and human tissues, revealing species-specific differences in glycan profiles and dynamics.

Cell Reports · Jul 1, 2025Peer-reviewedImmunology

Characterization of a novel mouse model of Dopamine Transporter Deficiency Syndrome and pharmacological therapeutic strategies

Emma E. Russo, Ameneh Rezayof, Conner W. Wallace, Erin Q. Williams, Pieter Beerepoot, Marija Milenkovic, Maria Novalen, Aled Blundell, Tatiana V. Lipina, Jason L. Locke, Raveen Christian, Peter S.B. Finnie, Landon J. Edgar, Rachel Fynvola Tyndale, Dawn E. Watkins‐Chow, , Ali Salahpour

This study creates a mouse model of DTDS with the A313V DAT variant and identifies two potential treatments, [a]MPT and AMPH, that reduce hyperactivity.

bioRxiv · Mar 21, 2025 · PreprintPharmacology & Toxicology